Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 received from Mr. Ravinder Gupta belongs to promoters group regarding sale of his holding.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd disclosed that Mr. Ravinder Gupta, part of the promoter group, sold 1,500 equity shares in the open market on September 26, 2025, at Rs. 950.88 per share, for a total value of Rs. 14,26,320. The sale was carried out under a trading plan submitted to the stock exchange on August 5, 2024. After the sale, his shareholding in the company declined from 5,500 shares (0.067%) to 4,000 shares (0.048%). The disclosure was filed under SEBI's insider trading regulations.
This is a small, pre-scheduled sale by a promoter group member and is unlikely to have any meaningful impact on the stock price or overall promoter holding. Shareholders should note it only as a routine regulatory compliance update.